| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |